Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
24.80
-0.20 (-0.80%)
Apr 14, 2026, 1:12 PM AST

TADAWUL:9620 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
20.3819.8618.0317.01
Revenue Growth (YoY)
2.62%10.11%6.04%-
Cost of Revenue
-10.479.878.7
Gross Profit
20.389.388.178.31
Selling, General & Admin
-4.694.154.68
Other Operating Expenses
17.92---0.11
Operating Expenses
17.924.273.824.58
Operating Income
2.465.124.343.73
Interest Expense
--0.07-0.09-0.1
Other Non Operating Income (Expenses)
-0---
Pretax Income
2.465.044.263.63
Income Tax Expense
0.490.260.10.12
Net Income
1.974.784.163.51
Net Income to Common
1.974.784.163.51
Net Income Growth
-58.85%14.85%18.47%-
Shares Outstanding (Basic)
221-
Shares Outstanding (Diluted)
221-
Shares Change (YoY)
21.95%38.36%--
EPS (Basic)
0.792.342.82-
EPS (Diluted)
0.792.342.82-
EPS Growth
-66.26%-16.99%--
Free Cash Flow
2.945.27-1.744.53
Free Cash Flow Per Share
1.182.58-1.18-
Dividend Per Share
-1.500--
Gross Margin
100.00%47.26%45.29%48.87%
Operating Margin
12.08%25.77%24.09%21.95%
Profit Margin
9.65%24.07%23.08%20.66%
Free Cash Flow Margin
14.45%26.55%-9.65%26.61%
EBITDA
3.396.055.174.63
EBITDA Margin
16.65%30.45%28.65%27.25%
D&A For EBITDA
0.930.930.820.9
EBIT
2.465.124.343.73
EBIT Margin
12.08%25.77%24.09%21.95%
Effective Tax Rate
20.04%5.24%2.27%3.32%
Advertising Expenses
-0.430.360.17
Source: S&P Global Market Intelligence. Standard template. Financial Sources.